Dr. Jerome Burke

About Dr. Jerome Burke

Dr. Jerome Burke, Jr., is a dedicated medical toxicologist with more than two decades of experience protecting public health. He is the program director for Research and Reporting at the Center for Drug Evaluation and Research, which is part of the U.S. Food and Drug Administration.

Burke previously contributed to the identification of the SARS coronavirus at National Institutes of Health. He also served as a member of the Infectious Disease Team within the U.S. Army during the COVID-19 pandemic.

As a toxicologist, he’s an expert in how chemicals and poisons affect the body. Burke’s work at the FDA helps make sure new drugs and products are safe for people. He has a background in trial management and as a clinical informaticist using technology and data analytics to improve patient care.

Burke studied molecular biology and chemistry at Winston-Salem State University. He then earned a Ph.D. in toxicology and cancer biology from the University of Kentucky, showing his deep understanding of how chemicals affect human health. 

Burke also earned a medical doctorate degree at the Washington University of Health and Science School of Medicine. To further enhance his knowledge, he received a Healthcare Management Graduate Certification at Johns Hopkins University. He also completed a fellowship in pulmonary-critical at the National Institutes of Health.

Jerome Burke’s Role as Medical Reviewer on Asbestos.com

Burke’s extensive background in medical toxicology makes him an excellent medical reviewer for The Mesothelioma Center at Asbestos.com, the nation’s most trusted mesothelioma resource.

His knowledge of how toxic asbestos exposure can lead to cancer ensures the topics and content on many of the informational pages on Asbestos.com meet medical and scientific standards regarding the toxicology of asbestos.

Specialties of Jerome Burke

• Clinical Trial Management
• Infectious Disease
• Preventative Medicine
• Public Health
• Medical Toxicology
• Translational Medicine

Experience and Medical Education

• Winston-Salem State University (B.S.)
• University of Kentucky College of Medicine (Ph.D.)
• Washington University of Health and Science School of Medicine (M.D.)
• Johns Hopkins University (Healthcare Management Graduate Certification)
• National Institutes of Health (Fellowship)

Awards and Recognition

• 2011: U.S. EPA Agency Award, Suzanne E. Olive Award for Exemplary Leadership
• 2010: U.S. EPA Agency Award, American Recovery and Reinvestment Act

Publications of Jerome Burke

• Data Evaluation Record (DER) for Special Study: Repeat Dose Comparative Cholinesterase Study of Malathion and Malaoxon in Juvenile Rats. Gerome Burke, Ph.D. PC Code 057701, DP Barcode: D332783. Data Evaluation Record Regulatory Registration Action. U.S. Environmental Protection Agency, Office of Prevention, Pesticides, and Toxic Substances, Office of Pesticide Programs. March 30, 2007.
• Flazasulfuron: Human Health Risk Assessment for the Proposed Uses on Golf Courses, Sod Farms, Professionally Managed Athletic Fields (College and Professional), and Commercial Lawns. Gerome Burke, Ph.D., Kelly O’Rourke. PC Code 119011, DP Barcode: D303573 & 0309442. Section 3 Regulatory Registration Action. U.S. Environmental Protection Agency, Office of Prevention, Pesticides, and Toxic Substances, Office of Pesticide Programs. November 16, 2005.
• Angiotensin II Regulates Oxygen Consumption. L. Cassis, M. Helton, V. English, and G. Burke. Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082. Am J Physiol Regulatory Integrative Comp. Physiol. 282: R445-R453, 2002.
• Cold exposure regulates the renin-angiotensin system. L. Cassis, A. Laughter, M. Fettinger, V. King, G. Burke and W. Akers, J. of Pharm. Exp. Ther. 286: 718 – 726, 1998.